Dianna is General Counsel of Inscripta, specializing in product protection strategies, transactional law and patent enforcement for life science companies. Dianna was previously Senior Vice President of Intellectual Property and Legal Affairs at Ariosa Diagnostics, Inc., acquired by Roche Molecular Systems in 2015. Dianna has been legal and IP counsel for various companies including Complete Genomics, Cambridge Antibody Technology (a wholly-owned subsidiary of AstraZeneca) and Elan Pharmaceuticals. In 2002, Dianna co-founded the Australian Stem Cell Centre (ASCC) in Melbourne, Australia, the first Australian Biotechnology Centre of Excellence. At the ASCC, Dianna was responsible for oversight of all operational, corporate, legal and intellectual property activities.